NuVasive
-
Regulatory
NuVasive Receives Latest FDA 510(k) Clearance for Pulse Platform and Announces Commercial Launch
First-of-its-kind platform integrates multiple technologies to address most common clinical challenges in spine surgery SAN DIEGO, July 30, 2021 /PRNewswire/ — NuVasive, Inc.…
Read More » -
Financial
NuVasive Announces Second Quarter 2021 Financial Results
— Net sales increase driven by recovery across all procedural segments and continued strong international growth — — Pulse platform…
Read More » -
Spine
NuVasive Launches Modulus ALIF 3D-Printed Porous Titanium Implant for Anterior Spine Surgery
SAN DIEGO, July 22, 2021 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with…
Read More » -
Financial
NuVasive Announces Conference Call and Webcast of Second Quarter 2021 Results
SAN DIEGO, July 14, 2021 /PRNewswire/ –NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally…
Read More » -
Regulatory
NuVasive Receives Latest CE Mark Approval for Pulse Platform and Starts Global Clinical Evaluations
— Clinical evaluations underway across multiple countries throughout Europe — SAN DIEGO, June 30, 2021 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in…
Read More » -
Spine
NuVasive Appoints Daniel J. Wolterman as Independent Board Chair
SAN DIEGO, May 19, 2021 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with…
Read More » -
Regulatory
MCRA CRO Assists Simplify Medical, Recently Acquired by NuVasive, on FDA-Approval for Two Level use of its Cervical Disc
– MCRA’s CRO assisted Simplify Medical, Inc. (Simplify Medical) with the conduct, execution and oversight of the clinical study, including…
Read More » -
Financial
NuVasive Announces First Quarter 2021 Financial Results
— Net sales increase driven by U.S. procedural volume improvement throughout the quarter and strong international growth — Simplify Cervical…
Read More » -
Regulatory
NuVasive’s Simplify Disc Receives FDA Approval for Two-Level Cervical Total Disc Replacement
Simplify® Cervical Artificial Disc achieved the highest overall clinical success rate at both one- and two-levels compared to any other…
Read More » -
Spine
NuVasive Announces Retirement of Gregory T. Lucier from Board of Directors
Mr. Lucier’s commitment to disruptive technology and global scale accelerated Company growth to more than $1 billion in net sales…
Read More » -
Spine
NuVasive and the International Spine Study Group Foundation Announce Expanded Long-Term Partnership with Initiation of Additional Clinical Studies
SAN DIEGO, March 16, 2021 /PRNewswire/ –NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine…
Read More » -
Financial
NuVasive Announces Fourth Quarter and Full Year 2020 Financial Results
SAN DIEGO, Feb. 25, 2021 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with…
Read More » -
Financial
NuVasive Acquires Simplify Medical
Simplify Cervical Artificial Disc provides NuVasive most clinically effective technology in the cervical total disc replacement (cTDR) procedure segment Expands…
Read More » -
Spine
NuVasive Expands Clinical Professional Development Program with New East Coast Experience Center in New York Metropolitan Area
SAN DIEGO, Feb. 8, 2021 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with…
Read More » -
Dr. Siddhartha Kadia to Join NuVasive Board of Directors
SAN DIEGO, Feb. 1, 2021 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally…
Read More »